Evaluating Treatable Traits Across the Spectrum of Chronic Obstructive Airways Disease
Recruiting
Observational Study
Airway Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University of Leeds · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Respiratory disease affects one in five people and is a leading cause of global morbidity and mortality. Chronic obstructive airways diseases encompass conditions characterised by expiratory airflow limitation, exertional dyspnoea, activity limitation and impaired quality of life. The most common conditions include chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, cystic fibros…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Prior diagnosis of airways disease in accordance with European Respiratory Society guidelines.
* Non / ex-smokers (packs recorded as cigarettes per day / years smoked).
* Male or female aged 18-65 years
* Ability to provide written informed consent.
* Full comprehension of spo…
Contacts